Carpenter Rick 4
4 · TANDEM DIABETES CARE INC · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Carpenter Rick
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-17+1,437→ 24,342 total - Tax Payment
Common Stock
2025-11-17$18.61/sh−456$8,486→ 24,053 total - Tax Payment
Common Stock
2025-11-17$18.61/sh−730$13,585→ 23,612 total - Exercise/Conversion
Common Stock
2025-11-17+897→ 24,509 total - Exercise/Conversion
Restricted Stock Unit
2025-11-17−1,437→ 2,874 total→ Common Stock (1,437 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-11-17−897→ 5,384 total→ Common Stock (897 underlying) - Award
Common Stock
2025-11-17$15.59/sh+339$5,285→ 22,905 total
Footnotes (7)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2025, through November 17, 2025. This transaction is also exempt under Rule 16b-3(c).
- [F2]Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F3]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F4]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F5]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F6]Awarded on May 23, 2024 pursuant to the 2023 Plan.
- [F7]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.